Optimizing treatment for nursing home residents with acute cholecystitis

优化疗养院居民急性胆囊炎的治疗

基本信息

项目摘要

Project Summary/Abstract Acute cholecystitis - infection of the gallbladder - is one of the most common gastrointestinal conditions in the United States. Removal of the gallbladder (cholecystectomy) is the only definitive treatment for acute cholecystitis. More than a third of patients with acute cholecystitis who do not undergo surgery will experience gallstone related complications within 2 years of initial diagnosis. For this reason, cholecystectomy at the time of initial episode is considered the standard of care. Whether the risks of surgery are lower than the burdens of recurrent disease in patients with limited life-expectancy is unclear. Surgical decision-making for elder nursing home residents is challenging. Our overarching research objective is to improve care for nursing home residents by providing them and their health care providers realistic information about risks and benefits of treatment for common surgical diseases. For some conditions that are usually treated surgically, the risks of surgery for nursing home residents may outweigh the burdens of future disease complications that may never occur during their remaining lifetime. [Nonsurgical] therapies such as percutaneous gallbladder drainage or antibiotic therapy alone may be more appropriate. The objective of the proposed study is to better understand the use and outcomes of surgery and [nonsurgical] therapy to treat acute cholecystitis in elder nursing home residents. To inform nursing home residents and their health care providers about risks and benefits of different treatment strategies our project has three specific aims: [1) To evaluate current treatments for acute cholecystitis among nursing home residents and determine resident and provider characteristics associated with the use of cholecystectomy and [nonsurgical] treatment, 2) to identify determinants of short term outcomes after surgery and [nonsurgical] treatment among nursing home residents with acute cholecystitis and compare the outcomes of residents undergoing surgical v nonsurgical treatment and 3) to determine the association between resident and provider characteristics and longitudinal functional outcomes, survival, and recurrent gallbladder disease after initial treatment for acute cholecystitis and compare longitudinal outcomes of residents undergoing surgical and nonsurgical treatment.] The approach is innovative because, in addition to comorbidity, we will evaluate the impact of cognitive and functional status - important and powerful predictors of life expectancy - on treatment choice and outcomes for acute cholecystitis in the entire nursing home population age 65 and older in the United States. This study is significant because currently there is no information about treatment and outcomes for this common disease in this large and vulnerable population. For individuals with limited life expectancy, determining the individualized treatment that alleviates suffering and best maintain function is essential. Better knowledge of the safety and effectiveness of alternative treatment strategies in subgroups of nursing home residents will minimize the harms of both undertreatment and overtreatment of this common disease.
项目摘要/摘要急性胆囊炎——胆囊感染——是最常见的疾病之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Emily Finlayson其他文献

Emily Finlayson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Emily Finlayson', 18)}}的其他基金

Optimizing treatment for nursing home residents with acute cholecystitis
优化疗养院居民急性胆囊炎的治疗
  • 批准号:
    8838030
  • 财政年份:
    2014
  • 资助金额:
    $ 32.34万
  • 项目类别:
Optimizing treatment for nursing home residents with acute cholecystitis
优化疗养院居民急性胆囊炎的治疗
  • 批准号:
    9027788
  • 财政年份:
    2014
  • 资助金额:
    $ 32.34万
  • 项目类别:
Functional Outcomes After Major Surgery in Nursing Home Residents
疗养院居民大手术后的功能结果
  • 批准号:
    7983774
  • 财政年份:
    2006
  • 资助金额:
    $ 32.34万
  • 项目类别:
Functional Outcomes After Major Surgery in Nursing Home Residents
疗养院居民大手术后的功能结果
  • 批准号:
    7152146
  • 财政年份:
    2006
  • 资助金额:
    $ 32.34万
  • 项目类别:
Functional Outcomes After Major Surgery in Nursing Home Residents
疗养院居民大手术后的功能结果
  • 批准号:
    7280371
  • 财政年份:
    2006
  • 资助金额:
    $ 32.34万
  • 项目类别:
Functional Outcomes After Major Surgery in Nursing Home Residents
疗养院居民大手术后的功能结果
  • 批准号:
    7478405
  • 财政年份:
    2006
  • 资助金额:
    $ 32.34万
  • 项目类别:
Functional Outcomes After Major Surgery in Nursing Home Residents
疗养院居民大手术后的功能结果
  • 批准号:
    7907665
  • 财政年份:
    2006
  • 资助金额:
    $ 32.34万
  • 项目类别:

相似海外基金

Comprehensive diagnosis of bacterial infection associated with acute cholecystitis using metagenomic approach
利用宏基因组学方法综合诊断急性胆囊炎相关细菌感染
  • 批准号:
    15K10198
  • 财政年份:
    2015
  • 资助金额:
    $ 32.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Optimizing treatment for nursing home residents with acute cholecystitis
优化疗养院居民急性胆囊炎的治疗
  • 批准号:
    8838030
  • 财政年份:
    2014
  • 资助金额:
    $ 32.34万
  • 项目类别:
Optimizing treatment for nursing home residents with acute cholecystitis
优化疗养院居民急性胆囊炎的治疗
  • 批准号:
    9027788
  • 财政年份:
    2014
  • 资助金额:
    $ 32.34万
  • 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
  • 批准号:
    6517993
  • 财政年份:
    2001
  • 资助金额:
    $ 32.34万
  • 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
  • 批准号:
    6594708
  • 财政年份:
    2001
  • 资助金额:
    $ 32.34万
  • 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
  • 批准号:
    6799078
  • 财政年份:
    2001
  • 资助金额:
    $ 32.34万
  • 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
  • 批准号:
    6661237
  • 财政年份:
    2001
  • 资助金额:
    $ 32.34万
  • 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
  • 批准号:
    6660453
  • 财政年份:
    2001
  • 资助金额:
    $ 32.34万
  • 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
  • 批准号:
    6941409
  • 财政年份:
    2001
  • 资助金额:
    $ 32.34万
  • 项目类别:
GALLBLADDER MUSCARINIC RECEPTORS IN ACUTE CHOLECYSTITIS
急性胆囊炎中的胆囊毒蕈碱受体
  • 批准号:
    6449709
  • 财政年份:
    2001
  • 资助金额:
    $ 32.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了